F&P Healthcare increases earnings guidance

Fisher & Paykel Healthcare has increased its earnings forecast for 2014 (the company has a 31 March year end), from NZ$85-90m to NZ$90-95m, up from NZ$77m a year earlier. Revenue is now expected to be NZ$625-645m based on a NZD/USD exchange rate of around 80 cents. For the six months ending 30 September management expects revenue from the Obstructive Sleep Apnoea division to increase 'about 14%', indicating that new mask releases are regaining market share. The Respiratory and Acute Care division, which chiefly sells breathing devices to hospitals, should increase revenue by a very impressive 18%. As we discussed in...

Fisher & Paykel Healthcare has increased its earnings forecast for 2014 (the company has a 31 March year end), from NZ$85-90m to NZ$90-95m, up from NZ$77m a year earlier. Revenue is now expected to be NZ$625-645m based on a NZD/USD exchange rate of around 80 cents.

{{content.question}}

{{ twilioFailed ? 'SMS Code Failed to Send…' : 'SMS Code Sent…' }}

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

We cannot send you a code via SMS to {{user.DayPhone}}

If you didn't receive SMS code please

SMS code cannot be sent due to: {{ twilioStatus }}

Please select one of the options below:

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa
Mastercard

The email address you entered is registered with InvestSMART.

Please login or select "Don't know password"

Please untick this box when using a public or shared device


Register as a new member

(using a different email)

Related Articles